COVID-19 and (hydroxy)chloroquine-azithromycin combination: Should we take the risk for our patients?
作者信息
Javelot Hervé, El-Hage Wissam, Meyer Guillaume, Becker Guillaume, Michel Bruno, Hingray Coraline
机构信息
Clinical Pharmacy Service, EPSAN, Brumath, France.
Laboratoire de Toxicologie et Pharmacologie Neuro Cardiovasculaire, Université de Strasbourg, Strasbourg, France.
出版信息
Br J Clin Pharmacol. 2020 Jun;86(6):1176-1177. doi: 10.1111/bcp.14335. Epub 2020 May 7.
Abstract
摘要
相似文献
1
COVID-19 and (hydroxy)chloroquine-azithromycin combination: Should we take the risk for our patients?2019冠状病毒病与羟氯喹-阿奇霉素联合用药：我们应该为患者冒这个险吗？
Br J Clin Pharmacol. 2020 Jun;86(6):1176-1177. doi: 10.1111/bcp.14335. Epub 2020 May 7.
2
QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin.在接受羟氯喹、氯喹或阿奇霉素治疗的不同城市新冠患者群体中QT间期延长。
J Interv Card Electrophysiol. 2020 Nov;59(2):337-345. doi: 10.1007/s10840-020-00822-x. Epub 2020 Jul 11.
3
QTc evaluation in COVID-19 patients treated with chloroquine/hydroxychloroquine: A letter to the editor.新冠病毒感染患者使用氯喹/羟氯喹治疗时的QTc评估：致编辑的一封信
Eur J Clin Invest. 2020 Nov;50(11):e13407. doi: 10.1111/eci.13407. Epub 2020 Sep 25.
4
"Off-label" use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers.羟氯喹、阿奇霉素、洛匹那韦-利托那韦和氯喹在 COVID-19 中的“超适应证”使用：法国药物警戒中心网络对心脏不良药物反应的调查。
Therapie. 2020 Jul-Aug;75(4):371-379. doi: 10.1016/j.therap.2020.05.002. Epub 2020 May 7.
5
Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection.氯喹、羟氯喹和阿奇霉素对 SARS-CoV-2 感染患者校正 QT 间期的影响。
Circ Arrhythm Electrophysiol. 2020 Jun;13(6):e008662. doi: 10.1161/CIRCEP.120.008662. Epub 2020 Apr 29.
6
QTc evaluation in COVID-19 patients treated with chloroquine/hydroxychloroquine.对接受氯喹/羟氯喹治疗的新冠病毒疾病患者进行QTc评估。
Eur J Clin Invest. 2020 Jun;50(6):e13258. doi: 10.1111/eci.13258. Epub 2020 May 18.
7
Recommendations for the measurement of the QT interval during the use of drugs for COVID-19 infection treatment. Updatable in accordance with the availability of new evidence.新型冠状病毒肺炎（COVID-19）感染治疗用药期间QT间期测量的建议。可根据新证据的获取情况进行更新。
J Interv Card Electrophysiol. 2020 Nov;59(2):315-320. doi: 10.1007/s10840-020-00765-3. Epub 2020 May 16.
8
QT interval evaluation associated with the use of hydroxychloroquine with combined use of azithromycin among hospitalised children positive for coronavirus disease 2019.2019冠状病毒病检测呈阳性的住院儿童中，羟氯喹与阿奇霉素联合使用相关的QT间期评估。
Cardiol Young. 2020 Oct;30(10):1482-1485. doi: 10.1017/S1047951120002425. Epub 2020 Jul 20.
9
COVID-19 and Chloroquine/Hydroxychloroquine: is there Ophthalmological Concern?新型冠状病毒肺炎与氯喹/羟氯喹：是否存在眼科方面的问题？
Am J Ophthalmol. 2020 May;213:A3-A4. doi: 10.1016/j.ajo.2020.03.028. Epub 2020 Mar 25.
10
The Use of "Novel Pharmacology" in the Treatment of COVID-19 and Potential Psychiatric Risks.“新型药理学”在新冠病毒疾病治疗中的应用及潜在精神风险
Prim Care Companion CNS Disord. 2020 May 21;22(3):20com02638. doi: 10.4088/PCC.20com02638.
引用本文的文献
1
Computational Screening Using a Combination of Ligand-Based Machine Learning and Molecular Docking Methods for the Repurposing of Antivirals Targeting the SARS-CoV-2 Main Protease.基于配体的机器学习和分子对接方法的组合进行计算筛选，以重新利用针对 SARS-CoV-2 主蛋白酶的抗病毒药物。
Daru. 2024 Jun;32(1):47-65. doi: 10.1007/s40199-023-00484-w. Epub 2023 Oct 31.
2
Potential Drugs in COVID-19 Management.新冠病毒管理中的潜在药物。
Curr Med Chem. 2024;31(22):3245-3264. doi: 10.2174/0929867331666230717154101.
3
Impact of SARS-CoV-2 on pregnancy outcomes (Review).严重急性呼吸综合征冠状病毒2（SARS-CoV-2）对妊娠结局的影响（综述）
Med Int (Lond). 2021 Oct 26;1(5):19. doi: 10.3892/mi.2021.19. eCollection 2021 Nov-Dec.
4
Pulmonary Delivery of Hydroxychloroquine Nanostructured Lipid Carrier as a Potential Treatment of COVID-19.羟氯喹纳米结构脂质载体的肺部给药作为COVID-19的一种潜在治疗方法
Polymers (Basel). 2022 Jun 28;14(13):2616. doi: 10.3390/polym14132616.
5
Protocol of Pakistan randomized and observational trial to evaluate coronavirus treatment among newly diagnosed patients with COVID-19: Azithromycin, Oseltamivir, and Hydroxychloquine.巴基斯坦一项评估新冠病毒19型（COVID-19）新诊断患者冠状病毒治疗方法的随机和观察性试验方案：阿奇霉素、奥司他韦和羟氯喹。
Pak J Med Sci. 2022 May-Jun;38(5):1401-1408. doi: 10.12669/pjms.38.5.5512.
6
Scoping insight on antiviral drugs against COVID-19.关于抗2019冠状病毒病抗病毒药物的综述性见解。
Arab J Chem. 2021 Oct;14(10):103385. doi: 10.1016/j.arabjc.2021.103385. Epub 2021 Aug 16.
7
Psychotropics and COVID-19: An analysis of safety and prophylaxis.精神药物与 COVID-19：安全性与预防分析。
Encephale. 2021 Dec;47(6):564-588. doi: 10.1016/j.encep.2021.08.002. Epub 2021 Sep 2.
8
Repurposing of antibiotics for clinical management of COVID-19: a narrative review.抗生素在 COVID-19 临床治疗中的再利用：叙述性综述。
Ann Clin Microbiol Antimicrob. 2021 May 21;20(1):37. doi: 10.1186/s12941-021-00444-9.
9
COVID-19 pandemic: Can zinc supplementation provide an additional shield against the infection?新冠疫情：补充锌能为预防感染提供额外防护吗？
Comput Struct Biotechnol J. 2021;19:1371-1378. doi: 10.1016/j.csbj.2021.02.015. Epub 2021 Mar 2.
10
In the Face of a Pandemic: The COVID-19 Infodemic.面对大流行：新冠疫情信息疫情
Int J Psychol Res (Medellin). 2020 Jul-Dec;13(2):6-8. doi: 10.21500/20112084.4891.
本文引用的文献
1
Patients with mental health disorders in the COVID-19 epidemic.新冠疫情期间患有精神健康障碍的患者。
Lancet Psychiatry. 2020 Apr;7(4):e21. doi: 10.1016/S2215-0366(20)30090-0.
2
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?氯喹抗冠状病毒的抗病毒作用的新见解：对 COVID-19 有何期待？
Int J Antimicrob Agents. 2020 May;55(5):105938. doi: 10.1016/j.ijantimicag.2020.105938. Epub 2020 Mar 12.
3
CredibleMeds.org: What does it offer?可信药物网：它提供了什么？
Trends Cardiovasc Med. 2018 Feb;28(2):94-99. doi: 10.1016/j.tcm.2017.07.010. Epub 2017 Aug 1.
4
Risk factors for QTc-prolongation: systematic review of the evidence.致 QT 间期延长的风险因素：证据的系统综述。
Int J Clin Pharm. 2017 Feb;39(1):16-25. doi: 10.1007/s11096-016-0414-2. Epub 2016 Dec 23.
5
Azithromycin, cardiovascular risks, QTc interval prolongation, torsade de pointes, and regulatory issues: A narrative review based on the study of case reports.阿奇霉素、心血管风险、QTc间期延长、尖端扭转型室速及监管问题：基于病例报告研究的叙述性综述
Ther Adv Infect Dis. 2013 Oct;1(5):155-65. doi: 10.1177/2049936113501816.
Zotero 插件